Small molecule new drug patent applied by Hengrui in recent years

Wo2007079666 paclitaxel derivative, for the treatment of tumor Wo2007085188 VEGFR / PDGFR inhibitors, sunitinib analogues, for cancer treatment Wo2008089636 DPP-4 inhibitor, wiggliptin analogue, in the treatment of type II diabetes Wo2008138184; wo2011095068 VEGFR / PDGFR inhibitor, sunitinib analogue, tumor treatment Wo2009024016 VEGFR / PDGFR inhibitors, sunitinib analogues, for cancer treatment Wo2009103218 TPO receptor agonist, eltrombopag analogue, for the treatment of thrombocytopenia, suspected to be hetrapa WO2009082881; WO2010099698; WO2010135944 DPP-4 inhibitor, xigliptin analogue, for the treatment of type II diabetes, it is suspected to be retagliptin Wo2011029265; wo2012122865; wo2013131424; wo2014008794 EGFR / HER2 inhibitor, dacomitinib analogue, for the treatment of lung cancer and breast cancer, i.e shr1258 (pyrrolidine?) Wo2012019426 PARP inhibitor, olaparib analogue, for the treatment of breast and ovarian cancer Wo2012019428 renin inhibitor, aliskirin analogue, for the treatment of hypertension Wo2012019430 PARP inhibitor, olaparib analogue, for the treatment of breast and ovarian cancer Wo2012019496 SGLT2 inhibitor, cigliptin analogue, in the treatment of type II diabetes mellitus, suspected to be henggliptin Wo2012088411 hedgehog inhibitor, in the treatment of basal skin cancer, suspected to be cimetidine Wo2013023511 P2Y12 receptor antagonist, ticagrelor analogue, for the treatment of thrombus Wo2013029431 GABA receptor agonist, benzodiazepine derivative, used for surgical anesthesia, suspected to be rimazazolam Wo2013053273 PI3K / mTOR inhibitor, dactolisib analogue, for the treatment of tumor, it is suspected to be umidiji Wo2013091539 JAK inhibitor, tofetinib analogue, in the treatment of rheumatoid arthritis, suspected to be shr0302 Wo2013104257 GPR40 agonist, fasiglifam (failed) analogue, in the treatment of type II diabetes, suspected to be furoglitazone Wo2013189241 Syk inhibitor, fostamatinib (failed) analogue, for rheumatoid arthritis Cn103382206 VEGFR / PDGFR inhibitor, for tumor treatment Wo2014014001 CETP inhibitor, dalcetrapib analogue, for the treatment of hyperlipidemia Wo201401428 CETP inhibitor, anacetrapib analogue, for the treatment of hyperlipidemia Wo2014019442 potassium competitive acid blocker, tak-438 analog, for the treatment of peptic ulcer.